Magnus Medical is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. The company received U.S. FDA Breakthrough Device Designation and clearance for the SAINT™ Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode. The SAINT Neuromodulation System is an integrated hardware, software, and cloud-computing system that uses structural and functional magnetic resonance imaging (MRI) to inform a proprietary algorithm to identify the optimal anatomic target for focused neuromodulation in people with MDD. This new approach is delivered on an accelerated timeline and is precisely tailored to each person’s brain connectivity. Images and animation courtesy of Magnus Medical, Inc. Rx only. Refer product labeling for contraindications, warnings, and precautions.